89bio | 4:持股变动声明-董事 Babler Martin
89bio | 3:首次持股声明-董事 Babler Martin
89bio | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
89bio | 4:持股变动声明-高管 PALEKAR ROHAN
89bio | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(14.8%),Peter Kolchinsky(14.8%)等
89bio | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
89bio | 4:持股变动声明-高管 PALEKAR ROHAN
89bio | 4:持股变动声明-高管 Martins Ryan
89bio | 4:持股变动声明-高管 PALEKAR ROHAN
89bio | 4:持股变动声明-高管 Le-Nguyen Quoc
89bio | 4:持股变动声明-高管 Mansbach Harry H
89bio | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等
89bio | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(2.10%),Deep Track Biotechnology Master Fund, Ltd.(2.10%)等
89bio | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(7.8%),BVF Inc.(7.8%)等
89bio | SC 13G:超过5%持股股东披露文件-RTW Investments, LP(6.0%),Roderick Wong, M.D.(6.0%)
89bio | 4:持股变动声明-高管 Martins Ryan
89bio | 4:持股变动声明-高管 Mansbach Harry H
89bio | 4:持股变动声明-高管 Le-Nguyen Quoc
89bio | 4:持股变动声明-高管 PALEKAR ROHAN
89bio | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(5.2%),Aaron Cowen(5.2%)等
暂无数据